Print full article

Morris Animal Foundation funds three equine medicine pilot studies

Study grants awarded to U.S., Dutch, and Australian researchers

Suggested Veterinary Products

Veterinary Business Financing
DR Wizard 2.0

The Morris Animal Foundation (MAF) will fund three pilot studies in horse health focusing on parasitic worms and equine metabolic syndrome.

The studies, which collectively awarded more than $30,000 in grants, are in addition to eight large-animal research projects the foundation announced in April.

Identifying Drug Resistant Parasites, University of Delaware

Uses molecular methods to identify which species of equine parasitic worms come back first after deworming. Understanding drug sensitivity and specific resistance mechanisms will help researchers develop more effective and targeted deworming strategies.

Evaluating New Equine Metabolic Syndrome Test, Murdoch University, Australia

Investigates a new laboratory test to improve diagnosis of equine metabolic syndrome (EMS), a metabolic and hormonal disorder in horses. A new efficient and cost-effective EMS test will help veterinarians better diagnose and manage this complex disease in horses.

Understanding the Role of the Microbiome in Equine Metabolic Syndrome, Utrecht University, the Netherlands

Studies the potential relationship between the bacterial composition of the microbiome and the development of EMS in Shetland ponies. Understanding how EMS develops, and the role of gut bacteria in this process, might provide new opportunities to intervene in early stages of disease and help prevent horses and ponies from getting EMS in the future.

Leave a Comment



Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.